Predicted protein targets (top 7)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TSHR | P16473 | 3/20 | 0.49 |
| ▸ | THRB | P10828 | 1/20 | 0.42 |
| ▸ | POLB | P06746 | 1/20 | 0.38 |
| ▸ | APEX1 | P27695 | 1/20 | 0.38 |
| ▸ | HTT | P42858 | 1/20 | 0.38 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.38 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.37 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL2552791 | 0.91 | TSHR (0.47) | TSHRTHRBPOLBAPEX1HTT | |
| SCHEMBL2246480 | 0.90 | TSHR (0.47) | TSHRTHRBPOLBAPEX1HTT | |
| SCHEMBL6692326 | 0.88 | TSHR (0.39) | TSHRTHRBPOLBAPEX1HTT | |
| SCHEMBL229726 | 0.87 | TSHR (0.49) | TSHRTHRBPOLBAPEX1HTT | |
| SCHEMBL133182 | 0.85 | TSHR (0.50) | TSHRTHRBPOLBAPEX1HTT | |
| SCHEMBL20658049 | 0.85 | TSHR (0.50) | TSHRTHRBPOLBAPEX1HTT | |
| SCHEMBL28617940 | 0.84 | TSHR (0.49) | TSHRTHRBPOLBAPEX1HTT | |
| SCHEMBL1833574 | 0.83 | TSHR (0.43) | TSHRTHRBPOLBAPEX1HTT | |
| SCHEMBL21268522 | 0.83 | TSHR (0.45) | TSHRTHRBPOLBAPEX1HTT | |
| SCHEMBL35128 | 0.83 | TSHR (0.55) | TSHRTHRBPOLBAPEX1HTT |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 977 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2025084741-A1 | POLYOLEFIN GRAFT COPOLYMER PRODUCED USING INITIATOR CONTAINING AZIDOFORMATE GROUP AND PRODUCTION METHOD THEREFOR | 세종대학교산학협력단 | 2025-04-24 | — | — | WO | claimed |
| CN-118852543-B | Modified polyurea resin for electrode plate, preparation method and application thereof, binder, electrode plate, preparation method of electrode plate and lithium battery | 长园新能源材料研究院(广东)有限公司 | 2025-03-21 | — | — | CN | claimed |
| CN-118852543-A | Modified polyurea resin for electrode plate, preparation method and application thereof, binder, electrode plate, preparation method of electrode plate and lithium battery | 长园新能源材料研究院(广东)有限公司 | 2024-10-29 | — | — | CN | claimed |
| US-11834429-B2 | Monoethylenically unsaturated monomers and uses thereof | BOSTIK SA (FR) | 2023-12-05 | — | — | US | claimed |
| US-20210179576-A1 | MONOETHYLENICALLY UNSATURATED MONOMERS AND USES THEREOF | UNIVERSITE DE RENNES (FR) | 2021-06-17 | — | — | US | claimed |
| CN-112533910-A | Monoethylenically unsaturated monomers and their use | 博斯蒂克股份公司 | 2021-03-19 | — | — | CN | claimed |
| EP-1675880-B1 | METHOD FOR PARTIAL OR TOTAL OXIDATION OF ONE OR SEVERAL THIOCARBONYLTHIO ENDS OF A POLYMER OBTAINED BY RADICAL POLYMERISATION CONTROLLED BY REVERSIBLE ADDITION-CLEAVAGE | RHODIA CHIMIE SA (FR) | 2019-03-13 | — | — | EP | claimed |
| US-20170298026-A1 | ALL PURPOSE RAFT AGENT | COMMONWEALTH SCIENTIFIC AND INDUSTRIAL RESEARCH ORGANISATION (AU) | 2017-10-19 | — | — | US | claimed |
| EP-3204353-A1 | ALL PURPOSE RAFT AGENT | Commonwealth Scientific and Industrial Research Organisation (AU) | 2017-08-16 | — | — | EP | claimed |
| US-20160340463-A1 | PROCESS FOR PREPARING A POLYMER | NEWSOUTH INNOVATIONS PTY LIMITED (AU) | 2016-11-24 | — | — | US | claimed |
| EP-1149075-A1 | SYNTHESIS OF DITHIOESTER CHAIN TRANSFER AGENTS AND USE OF BIS(THIOACYL) DISULFIDES OR DITHIOESTERS AS CHAIN TRANSFER AGENTS | E.I. DU PONT DE NEMOURS AND COMPANY (US) | 2001-10-31 | — | — | EP | claimed |
| US-6291620-B1 | Polymer synthesis | E. I. DU PONT DE NEMOURS AND COMPANY | 2001-09-18 | — | — | US | claimed |
| EP-0791016-B1 | POLYMER SYNTHESIS | DU PONT (US) | 2000-07-12 | — | — | EP | claimed |
| WO-2000035960-A2 | OLIGOMERIZATION, POLYMERIZATION AND COPOLYMERIZATION OF SUBSTITUTED AND UNSUBSTITUTED α-METHYLENE-η-BUTYROLACTONES AND PRODUCTS THEREOF | E.I. DU PONT DE NEMOURS AND COMPANY (US) | 2000-06-22 | — | — | WO | claimed |
| EP-1003793-A1 | FUNCTIONALIZED DIENE OLIGOMERS | E.I. DU PONT DE NEMOURS AND COMPANY (US) | 2000-05-31 | — | — | EP | claimed |
| WO-1999009077-A1 | FUNCTIONALIZED DIENE OLIGOMERS | E.I. DU PONT DE NEMOURS AND COMPANY (US) | 1999-02-25 | — | — | WO | claimed |
| WO-1999005099-A1 | SYNTHESIS OF DITHIOESTER CHAIN TRANSFER AGENTS AND USE OF BIS(THIOACYL) DISULFIDES OR DITHIOESTERS AS CHAIN TRANSFER AGENTS | COMMONWEALTH SCIENTIFIC AND INDUSTRIAL RESEARCH ORGANISATION (AU) | 1999-02-04 | — | — | WO | claimed |
| US-5847060-A | Functionalized diene oligomers | E. I. DU PONT DE NEMOURS AND COMPANY (US) | 1998-12-08 | — | — | US | claimed |
| EP-0791016-A1 | POLYMER SYNTHESIS | E.I. DU PONT DE NEMOURS AND COMPANY (US) | 1997-08-27 | — | — | EP | claimed |
| WO-1996015157-A1 | POLYMER SYNTHESIS | E.I. DU PONT DE NEMOURS AND COMPANY (US) | 1996-05-23 | — | — | WO | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-11834429-B2 | Monoethylenically unsaturated monomers and uses thereof | MEP1A, MEP1B, ALOX5 | TSHR 4885/4885THRB 4861/4885POLB 2550/4885 |
| US-20170298026-A1 | ALL PURPOSE RAFT AGENT | NPC1L1, RFTN1, SGMS2 | TSHR 4058/4885THRB 4068/4885POLB 2675/4885 |
| US-20210179576-A1 | MONOETHYLENICALLY UNSATURATED MONOMERS AND USES THEREOF | MEP1A, MEP1B, ALOX5 | TSHR 4885/4885THRB 4861/4885POLB 2550/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.